Customer Requirement
A pharmaceutical company required support in preparing a clinical overview along with a justification for a BA/BE study waiver for a generic drug product.
The client needed to ensure that the submission aligned with regulatory expectations and adequately addressed requirements related to product comparability, safety, and efficacy.
Problem Statement
The client faced several challenges during the regulatory submission process, including:
- Regulatory queries regarding the absence of BA/BE studies
- Need for a clear and structured justification for the biowaiver
- Lack of a detailed clinical overview aligned with expectations
- Risk of delays or rejection due to unresolved concerns
These challenges impacted the overall submission timeline and approval readiness.
Key Objective
To develop a scientifically sound biowaiver justification and a comprehensive clinical overview that effectively addresses regulatory expectations and supports product approval.
Regulatory Support & Outcome
A structured approach was followed to address regulatory queries and strengthen the submission. The biowaiver justification was aligned with applicable guidelines, supported by available data.
A clinical overview was developed to present key aspects related to safety, efficacy, and product comparability in a clear and compliant manner.
This approach helped streamline communication with the regulatory authority and ensured that concerns were addressed effectively.
Business Impact
- Improved clarity in regulatory responses
- Reduced risk of delays and objections
- Strengthened overall submission quality
- Supported progress toward product approval
Key Learning
Clear justification and well-structured documentation are essential when pursuing biowaivers. Early alignment with regulatory expectations helps minimize queries and supports smoother approval pathways.
Read more from here: Artwork Development for Multi-Country African Markets Submissions